arrow
S

Stephan Siegel

Bayer AG
H指数:19
被引数:1,255
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mechanisms of resistance to BAY 2927088, the first reversible inhibitor targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
2023-12-010
PRE
Preclinical activity of BAY 2927088 in HER2 mutant non-small cell lung cancer
2023-04-042
PRE
Mechanisms of resistance to BAY 2927088, the first reversible inhibitor targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
2023-04-040
PRE
Discovery and characterization of orally bioavailable 4-chloro-6-fluoroi-sophthalamides as covalent PPARG inverse-agonists
2023-01-014
OAAI
Linker-Dependent Folding Rationalizes PROTAC Cell Permeability
2022-09-2857
OAAI
Discovery and characterization of BAY-6035, a novel benzodiazepine-based SMYD3 inhibitor
2018-07-011
PRE
Super-enhancers define a proliferative PGC-1α-expressing melanoma subgroup sensitive to BET inhibition
2017-10-0934
OAAI
BAY-299, a novel chemical probe for in-depth analysis of the function of the bromodomain proteins BRPF2 and TAF1
2017-07-011
PRE
Probing the cancer epigenome: empowering target validation by open innovation
2017-07-010
PRE
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains

苯并异喹啉二酮作为BRPF2和TAF1/TAF1L溴结构域的有效和选择性抑制剂

2017-05-0154
OAAI
In vivo efficacy of BET inhibitor BAY 1238097 in preclinical models of melanoma and lung cancer
2016-07-150
PRE
The BET inhibitor BAY 1238097 shows efficacy in BRAF wild-type and mutant melanoma models
2016-07-151
PRE
Identification and characterization of BRPF1 bromodomain inhibitors
2016-07-151
PRE
BAY 1238097, a novel BET inhibitor with strong efficacy in hematological tumor models
2015-08-017
PRE
Targeting BET bromodomains for cancer treatment
2015-06-16152
PREAI
Suppression of c-Myc oncogene and hematological tumor growth by a novel benzazepine BET inhibitor
2014-11-010
PREAI
New benzazepine BET-inhibitors with improved oral bioavailability
2014-10-012
PRE
Selective indole-based ECE inhibitors:: Synthesis and pharmacological evaluation
2006-01-058
PREAI
New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activity
2004-02-0168
OAAI
Memory of chirality in electron transfer mediated benzylic umpolung reactions of arene-Cr(CO)3 complexes
1999-06-0162
PREAI